Delivery Order SPE2DE24D0021-SPE2D625F3NLK
- Not listed
- Fisher Scientific Company L.L.C. received a fixed-price delivery order contract from the Medical Supply Chain, a defense-focused federal agency, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, valued at $2,156.00, was awarded on September 10, 2025, with an ultimate completion date of September 17, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, awarded through open...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,540.27 on August 4, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by August 11, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued without a set-aside designation, reflecting...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,322.00 for BinaxNOW COVID-19 antigen testing kits on April 30, 2025, with an ultimate completion date of May 7, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-oriented federal agency, and will be performed in Pittsburgh, Pennsylvania. As a child contract, this delivery order is part of a larger contracting vehicle, leveraging Fisher Scientific's established...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. received a $3,920 fixed-price delivery order from the Medical Supply Chain, a defense-focused federal agency, for BinaxNow COVID-19 antigen testing kits. The contract is effective through September 12, 2025, with pricing subject to economic price adjustment provisions. This delivery order, which represents a child contract under a larger vehicle, carries no set-aside designation, reflecting Fisher Scientific's competitive standing in federal procurement. The kits...
- The U.S. Medical Supply Chain, a Defense Department component, awarded a $1,546.93 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on May 6, 2025, for BinaxNOW COVID-19 antigen testing kits. The contract is set to be completed by June 6, 2025, with performance taking place in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,036.00 for BINAXNOW COVID-19 40S test kits on August 15, 2025, by the Defense Medical Supply Chain, with an ultimate completion date of August 22, 2025. This is a fixed price contract with economic price adjustment provisions and carries no set-aside designation, reflecting open competition procurement. The contract specifies performance in Pittsburgh, PA 15275. As a child contract under a larger procurement vehicle, this...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3NLKDelivery Order
Fisher Scientific Company L.L.C. received a delivery order award valued at $3,920 for BinaxNow COVID-19 test kits under a fixed-price contract with economic price adjustment. The order, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, awarded through open competition to support the Medical Supply Chain, a defense-focused federal agency function. Fisher Scientific, a major supplier of scientific products and laboratory equipment registered in SAM.gov since July 2001, has extensive experience fulfilling similar supply contracts across multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense. The delivery order represents a small procurement within Fisher Scientific's broader portfolio of federal contracts. The company maintains significant standing agreements with federal agencies, including a $1.65 million Blanket Purchase Agreement with the Department of Veterans Affairs for toxicology and drug abuse reagents spanning October 2025 through September 2030. Fisher Scientific's selection for this COVID-19 testing supply order underscores its established capability as a reliable vendor for specialized medical and laboratory supplies supporting federal health and defense initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/16/25 |